Efficacy of metformin in mediating cellular uptake and inducing apoptosis activity of doxorubicin-Reference-Cited by-同舟云学术

Efficacy of metformin in mediating cellular uptake and inducing apoptosis activity of doxorubicin

Published:2018-11 Issue: Volume:99 Page:200-212
ISSN:0273-2300
Container-title:Regulatory Toxicology and Pharmacology
language:en
Short-container-title:Regulatory Toxicology and Pharmacology

Author:

Hoseini Shafa Maryam,Jalal Razieh,Kosari Negin,Rahmani Farzad

Funder

Ferdowsi University of Mashhad

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference63 articles.

1. Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ;Abbasi;Res. Pharm. Sci.,2016

2. Metformin and cancer stem cells: old drug, new targets;Bednar;Canc. Prev. Res.,2012

3. Optimized stem cell detection using the DyeCycle-triggered side population phenotype;Boesch;Stem Cell. Int.,2016

4. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth;Buzzai;Canc. Res.,2007

5. Metformin induced AMPK activation, G0/G1 phase cell cycle arrest and the inhibition of growth of esophageal squamous cell carcinomas in vitro and in vivo;Cai;PLoS One,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic anticancer effects of doxorubicin and metformin combination therapy: A systematic review;Translational Oncology;2024-07

2. Plant-Derived Bioactive Compounds: Exploring Neuroprotective, Metabolic, and Hepatoprotective Effects for Health Promotion and Disease Prevention;Pharmaceutics;2024-04-24

3. pH-responsive star-shaped poly (ε-carprolactone)-co-poly maleic anhydride micelles for synergistic breast cancer combination chemotherapy;Reactive and Functional Polymers;2023-12

4. Synergistic effect of metformin and doxorubicin on the metastatic potential of T24 cells;Acta Histochemica;2023-01

5. Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancer;Biomedicine & Pharmacotherapy;2022-05